SHERRI NEWTON: Open Payments
NPI 1841624244 · BARDSTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 33 payments from 10 companies in 2025. Trend: 2023 $241 · 2024 $384 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $197 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| PFIZER INC. | 4 | $72 |
| Novo Nordisk Inc | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Astellas Pharma US Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, PREVNAR 20, UBRELVY, TRINTELLIX, TRELEGY ELLIPTA, QULIPTA, Ozempic.
Industry payments across KY — which companies pay providers there.
